|
|
Thomson Financial Business Description:
| The Group's principal activities are developing, producing and marketing vaccines and antibodies against infectious diseases for private and public markets worldwide. The Group operates in three main markets: paediatric, travel and endemic and respiratory. Paediatric products include Quinvaxem, Epaxal, Hepavax-Gene and MoRu-Viraten. Travel and endemic products include Epaxal, Vivotif and Dukoral. Respiratory product includes Inflexal. The Group's research and development focusses on influenza, tubercolosis and malaria vaccine, rabies monocial antibody cocktail, ebola, HIV and yellow fever vaccine. The Group uses five technologies: PER.C6, AdVac, MAbstract, STAR and Virosome. The Group markets its products in 60 countries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Crucell NV
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
